GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC_CFI_620/2025, UPC_CFI_1509/2025, UPC_CFI_1511/2025

GlaxoSmithKline Biologicals SA v. Pfizer et al.

Date
2026-02-25
Division
The Hague (NL) Local Division
Type of action
Infringement Action
Language
EN

Metadata

Case IDUPC_CFI_620-2025-UPC_CFI_1509-2025-UPC_CFI_1511-2025-9ff9b86c19a4
Case number
Registry numberUPC_CFI_620/2025, UPC_CFI_1509/2025, UPC_CFI_1511/2025
Order reference
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 5

1 The Hague Local Division UPC_CFI_620/2025 UPC_CFI_1509/2025 UPC_CFI_1511/2025 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 25/02/2026 R.9 CLAIMANT GlaxoSmithKline Biologicals SA,Rue de l’Institut 89, 1330 Rixensart, Belgium Represented by Carlos Andres van Staveren, Tjibbe Douma, Nicole Jadeja (Bird & Bird) DEFENDANTS 1. C.P. Pharmaceuticals International C.V ., Rivium Westlaan 142, 2909LD Capelle aan den Ijssel, the Netherlands 2. Pfizer Export B.V., Rivium Westlaan 142, 2909 LD Capelle aan den IJssel, the Netherlands 3. Pfizer B.V., Rivium Westlaan 142, 2909 LD Capelle aan den IJssel, the Netherlands 4. Pfizer Manufacturing Belgium N.V., Rijksweg 12, 2870 Puurs-Sint-Amands, Belgium 5. Pfizer Service Company B.V./S.r.l., Hoge Wei 10, 1930 Zave ...